Ginkgo Bioworks Holdings, Inc., alongside its subsidiary entities, provides an advanced technological platform focused on the engineering of cells. This proprietary system is utilized to manipulate cellular functions, facilitating the biological creation of various products. These outputs span from innovative pharmaceutical treatments and vital food components to sustainable chemicals designed to replace those traditionally sourced from petroleum. The enterprise caters to a broad spectrum of industries, encompassing specialized chemical manufacturing, the agricultural sector, food production, consumer goods, and pharmaceuticals. Furthermore, Ginkgo Bioworks has forged a partnership with Selecta Biosciences, Inc., for the joint advancement of the ImmTOR technology platform. The company, founded in 2008, is headquartered in Boston, Massachusetts.

CEO

Dr. Jason Kelly Ph.D.

Employees

485

Country

United States

ISIN

US37611X1182

Listings

0 Comments

Share your thoughts

FAQ

What is Ginkgo Bioworks stock price today?▼

The current price of DNA-WT is $0.01 USD — it has decreased by -37.62% in the past 24 hours. Watch Ginkgo Bioworks stock price performance more closely on the chart.

What is Ginkgo Bioworks stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Ginkgo Bioworks stocks are traded under the ticker DNA-WT.

What is Ginkgo Bioworks revenue for the last year?▼

Ginkgo Bioworks revenue for the last year amounts to 251.46M USD.

What is Ginkgo Bioworks net income for the last year?▼

DNA-WT net income for the last year is -892.87M USD.

How many employees does Ginkgo Bioworks have?▼

As of July 20, 2026, the company has 485 employees.

In which sector is Ginkgo Bioworks located?▼

Ginkgo Bioworks operates in the Health & Wellness sector.

When did Ginkgo Bioworks complete a stock split?▼

Ginkgo Bioworks has not had any recent stock splits.

Where is Ginkgo Bioworks headquartered?▼

Ginkgo Bioworks is headquartered in Boston, United States.